UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000051435
Receipt number R000058671
Scientific Title Alternation of gut microbiota by perioperative medicine for congenital heart disease: a observational study
Date of disclosure of the study information 2023/06/23
Last modified on 2024/01/22 13:45:27

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Alternation of gut microbiota by perioperative medicine for congenital heart disease: a observational study

Acronym

Alternation of gut microbiota by congenital heart disease surgery

Scientific Title

Alternation of gut microbiota by perioperative medicine for congenital heart disease: a observational study

Scientific Title:Acronym

Alternation of gut microbiota by congenital heart disease surgery

Region

Japan


Condition

Condition

Congenital heart disease

Classification by specialty

Cardiology Cardiovascular surgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The aim of this study is to investigate the alternation of gut microbiota caused by perioperative medicine for congenital heart disease in neonates and infants.

Basic objectives2

Bio-equivalence

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

The alternation of gut microbiota alpha- or beta-diversity between preoperative period and 7days after surgery.

Key secondary outcomes

The alternation of the relative abundances of bacteria between preoperative period and 7days after surgery.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

1 days-old <=

Age-upper limit

1 years-old >

Gender

Male and Female

Key inclusion criteria

Neonates and infants who undergo the surgery for congenital heart disease

Key exclusion criteria

Children who have gastrointestinal disease
Children who eat baby food
Children who has a history of surgery or receiving antibiotics

Target sample size

16


Research contact person

Name of lead principal investigator

1st name Junichi
Middle name
Last name Ohba

Organization

Hokkaido Medical Center for Child Health and Rehabilitation

Division name

Intensive care department

Zip code

060-0041

Address

240-6, Kanayama 1 jo, 1 cho-me, Teine-ku, Sapporo, Hokkaido

TEL

011-694-5696

Email

obajun@gmail.com


Public contact

Name of contact person

1st name Tomohiro
Middle name
Last name Chaki

Organization

Sapporo Medical University School of Medicine

Division name

Department of Anesthesiology

Zip code

060-8543

Address

291, South 1, West 16, Chuo-ku, Sapporo, Hokkaido

TEL

011-611-2111

Homepage URL


Email

chakitomohiro0728@yahoo.co.jp


Sponsor or person

Institute

Hokkaido Medical Center for Child Health and Rehabilitation

Institute

Department

Personal name



Funding Source

Organization

Hokkaido Medical Center for Child Health and Rehabilitation

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Institutional review board of Hokkaido Medical Center for Child Health and Rehabilitation

Address

291, South 1, West 16, Chuo-ku, Sapporo, Hokkaido

Tel

011-691-5696

Email

obajun@gmail.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 06 Month 23 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2023 Year 06 Month 08 Day

Date of IRB

2023 Year 06 Month 08 Day

Anticipated trial start date

2023 Year 06 Month 23 Day

Last follow-up date

2026 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

In this study, the change of gut microbiota during perioperative period is going to be analyzed and evaluated.


Management information

Registered date

2023 Year 06 Month 23 Day

Last modified on

2024 Year 01 Month 22 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000058671


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name